researchdrivelogo.jpg
Technological Advancements in Treatment Procedures Expected to Surge the Global Radiation Oncology Market in Upcoming Years, 2020-2027 – Exclusive Report [248 Pages] By Research Dive
25 oct. 2021 09h00 HE | Research Dive
New York, USA, Oct. 25, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiation oncology market is anticipated to generate a revenue of $10,679.7 million by...
Cancer Immunotherapy Market To Reach USD 242.86 Billion By 2026 | Reports And Data
17 juil. 2019 11h02 HE | Reports and Data
New York, July 17, 2019 (GLOBE NEWSWIRE) -- Increasing demand for cancer immunotherapy in hospitals, cancer research centers, and clinics coupled with high investment in R&D of cancer...
Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial
Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today...